Manhattan Scientifics Inc (MHTX) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
244 FIFTH AVENUE NEW YORK, NY 10001 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 369 - Miscellaneous Electrical Machinery, Equipment, and Supplies (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 175 | 232 | 353 | 261 | 87 | 269 | |||
| Cash and cash equivalents | 175 | 232 | 353 | 261 | 87 | 269 | |||
| Receivables | 300 | 300 | 300 | ||||||
| Prepaid expense | 14 | 15 | 12 | 13 | 11 | 9 | |||
| Total current assets: | 189 | 547 | 665 | 574 | 98 | 278 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 1 | 4 | 6 | 4 | |||||
| Long-term investments and receivables | 1,354 | 5,505 | |||||||
| Long-term investments | 1,354 | 5,505 | |||||||
| Intangible assets, net (including goodwill) | 23 | ||||||||
| Intangible assets, net (excluding goodwill) | 23 | ||||||||
| Other noncurrent assets | 2 | 2 | |||||||
| Other undisclosed noncurrent assets | 841 | 2,903 | 6,177 | 1,647 | 1,206 | 5,038 | |||
| Total noncurrent assets: | 842 | 2,907 | 6,183 | 1,651 | 2,562 | 10,568 | |||
| TOTAL ASSETS: | 1,031 | 3,454 | 6,848 | 2,225 | 2,660 | 10,846 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,439 | 1,129 | 853 | 1,860 | 221 | 209 | |||
| Accrued liabilities | 1,439 | 1,129 | 853 | 1,860 | |||||
| Other undisclosed accounts payable and accrued liabilities | 221 | 209 | |||||||
| Debt | 110 | 150 | 150 | ||||||
| Due to related parties | 1,531 | 1,418 | |||||||
| Other undisclosed current liabilities | 119 | 82 | 9 | 234 | |||||
| Total current liabilities: | 1,668 | 1,361 | 1,012 | 2,094 | 1,752 | 1,627 | |||
| Noncurrent Liabilities | |||||||||
| Other undisclosed noncurrent liabilities | 104 | 78 | |||||||
| Total noncurrent liabilities: | 104 | 78 | |||||||
| Total liabilities: | 1,668 | 1,361 | 1,116 | 2,172 | 1,752 | 1,627 | |||
| Temporary equity, carrying amount | 1,058 | 1,058 | 1,058 | ||||||
| Equity | |||||||||
| Equity, attributable to parent, including: | (1,695) | 1,035 | 4,674 | (1,028) | (150) | 8,161 | |||
| Common stock | 559 | 559 | 559 | 558 | 534 | 534 | |||
| Additional paid in capital | 68,996 | 68,996 | 68,996 | 67,632 | 67,289 | 67,289 | |||
| Accumulated deficit | (71,250) | (68,520) | (64,881) | (69,195) | (67,973) | (59,662) | |||
| Other undisclosed equity, attributable to parent | (23) | ||||||||
| Other undisclosed equity | 1,058 | 1,058 | 23 | ||||||
| Total equity: | (637) | 1,035 | 5,732 | (1,005) | (150) | 8,161 | |||
| Other undisclosed liabilities and equity | 1,058 | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 1,031 | 3,454 | 6,848 | 2,225 | 2,660 | 10,846 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 50 | 50 | 50 | 97 | 142 | |||
| Cost of revenue (Cost of Goods and Services Sold) | (189) | |||||||
| Gross profit: | 50 | 50 | 50 | 97 | (47) | |||
| Operating expenses | (729) | (737) | (725) | (1,122) | (1,448) | (2,420) | ||
| Other undisclosed operating income | 189 | |||||||
| Operating loss: | (679) | (687) | (675) | (1,025) | (1,448) | (2,278) | ||
| Nonoperating income (expense) | (2,051) | (2,952) | 4,989 | (197) | 7,940 | |||
| Investment income, nonoperating | (2,030) | (192) | 7,940 | |||||
| Other nonoperating expense | ||||||||
| Interest and debt expense | (21) | (26) | (25) | 5 | ||||
| Income (loss) from continuing operations: | (2,751) | (3,665) | 4,289 | (1,217) | (1,448) | 5,662 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | (3,665) | 4,289 | (1,217) | (1,448) | 5,662 | ||
| Other undisclosed net income (loss) | 26 | (5) | ||||||
| Net income (loss): | (2,751) | (3,639) | 4,289 | (1,222) | (1,448) | 5,662 | ||
| Other undisclosed net income (loss) attributable to parent | 21 | 25 | (6,886) | (4,116) | ||||
| Net income (loss) available to common stockholders, diluted: | (2,730) | (3,639) | 4,314 | (1,222) | (8,334) | 1,546 | ||
Comprehensive Income ($ in thousands)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (2,751) | (3,639) | 4,289 | (1,222) | (1,448) | 5,662 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (2,751) | (3,639) | 4,289 | (1,222) | (1,448) | 5,662 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.